Media Release | November 22, 2012
A well-established family of drugs used to treat parasitic diseases is showing surprising potential as a therapy for tuberculosis (TB), according to new research from University of British Columbia microbiologists.
Media Release | September 10, 2012
Researchers with the Neglected Global Diseases Initiative (NGDI) at the University of British Columbia have attracted more than $20 million in funding to find ways to eliminate diseases and conditions that kill millions of people in developing countries worldwide.
Media Release | June 5, 2012
A drug delivery system developed through the University of British Columbia’s Neglected Global Diseases Initiative and licensed to iCo Therapeutics Inc. will receive $1.1 million from the National Research Council of Canada (NRC) for clinical development as a treatment for HIV patients.
UBC, CFRI and BC Children’s researchers to lead $2.8-million project to reduce deadly infection in Bangladeshi mothers, children
Media Release | December 1, 2011
Researchers from the University of British Columbia, Child & Family Research Institute (CFRI) and BC Children’s Hospital (BCCH) have won a $2.8-million grant from the Canadian International Development Agency (CIDA) to improve the survival rate of Bangladeshi mothers, newborns and young children through the prevention of sepsis, a life-threatening form of infection in which the bloodstream is overwhelmed by bacteria.
Media Release | August 30, 2011
Three research projects at the University of British Columbia have won five-year grants totaling nearly $6 million from the Canadian Institutes of Health Research (CIHR) to promote greater equity in global health.
Media Release | December 3, 2010
The University of British Columbia has received a $7 million grant from the Bill & Melinda Gates Foundation. UBC researchers working at the Child & Family Research Institute will test new strategies for the monitoring, prevention, and treatment of pre-eclampsia.